Search Results - "Camacho Rovira, D"

Efficacy and safety of collagenase Clostridium histolyticum in Peyronie's disease following a modified treatment protocol by García Cruz, E, Mercader Barrull, C, Camacho Rovira, D, Alcaraz Asensio, A

“…INTRODUCTIONCollagenase Clostridium histolyticum (CCH) is the only approved treatment for conservative management of Peyronie's disease (PD) that has…”
Get full text

Efficacy and safety of collagenase Clostridium histolyticum in Peyronie’s disease following a modified treatment protocol by García Cruz, E., Mercader Barrull, C., Camacho Rovira, D., Alcaraz Asensio, A.

“…Collagenase Clostridium histolyticum (CCH) is the only approved treatment for conservative management of Peyronie’s disease (PD) that has demonstrated efficacy…”
Get full text

First 3D holmium laser enucleation of the prostate (3D-HoLEP) by Sanchez Macias, J., Franco, M., Pardo, A., Camacho Rovira, D., Calaf, O., Mercader, C., Alcaraz, A.

Get full text

V67 - First 3D holmium laser enucleation of the prostate (3D-HoLEP) by Sanchez Macias, J., Franco, M., Pardo, A., Camacho Rovira, D., Calaf, O., Mercader, C., Alcaraz, A.

Get full text

Holmium laser transurethral enucleation of the prostate 100 W vs 120 W: 12-month retrospective data from a single surgeon experience by Franco, M., Sanchez Macias, J., Mercader, C., Pardo, A., Camacho Rovira, D., Calaf, O., D’Anna, M., Rifa Lapieza, L., Alcaraz, A.

Get full text

PT179 - Holmium laser transurethral enucleation of the prostate 100 W vs 120 W: 12-month retrospective data from a single surgeon experience by Franco, M., Sanchez Macias, J., Mercader, C., Pardo, A., Camacho Rovira, D., Calaf, O., D’Anna, M., Rifa Lapieza, L., Alcaraz, A.

Get full text